Relation of Contrast-Induced Nephropathy to Long-Term Mortality After Percutaneous Coronary Intervention

There is little information on the effect of contrast-induced nephropathy (CIN) on long-term mortality after percutaneous coronary intervention in patients with or without chronic kidney disease (CKD). Of 4,371 patients who had paired serum creatinine (SCr) measurements before and after percutaneous...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2014-08, Vol.114 (3), p.362-368
Hauptverfasser: Abe, Mitsuru, MD, Morimoto, Takeshi, MD, MPH, Akao, Masaharu, MD, Furukawa, Yutaka, MD, Nakagawa, Yoshihisa, MD, Shizuta, Satoshi, MD, Ehara, Natsuhiko, MD, Taniguchi, Ryoji, MD, Doi, Takahiro, MD, Nishiyama, Kei, MD, Ozasa, Neiko, MD, Saito, Naritatsu, MD, Hoshino, Kozo, MD, Mitsuoka, Hirokazu, MD, Toma, Masanao, MD, Tamura, Toshihiro, MD, Haruna, Yoshisumi, MD, Kita, Toru, MD, Kimura, Takeshi, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is little information on the effect of contrast-induced nephropathy (CIN) on long-term mortality after percutaneous coronary intervention in patients with or without chronic kidney disease (CKD). Of 4,371 patients who had paired serum creatinine (SCr) measurements before and after percutaneous coronary intervention and were discharged alive in the Coronary REvascularization Demonstrating Outcome Study in Kyoto registry, the incidence of CIN (an increase in SCr of ≥0.5 mg/dl from the baseline) was 5% in our study cohort. The rate of CIN in patients with CKD was 11%, although it was 2% without CKD (p
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2014.05.009